OneDigital Investment Advisors LLC Buys 2,641 Shares of Stryker Co. (NYSE:SYK)

OneDigital Investment Advisors LLC increased its position in Stryker Co. (NYSE:SYK - Free Report) by 13.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,709 shares of the medical technology company's stock after buying an additional 2,641 shares during the quarter. OneDigital Investment Advisors LLC's holdings in Stryker were worth $8,176,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. TD Waterhouse Canada Inc. boosted its holdings in shares of Stryker by 0.7% during the 4th quarter. TD Waterhouse Canada Inc. now owns 121,239 shares of the medical technology company's stock worth $43,657,000 after buying an additional 890 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Stryker by 63.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 22,350 shares of the medical technology company's stock worth $8,047,000 after purchasing an additional 8,687 shares in the last quarter. Thematics Asset Management bought a new position in shares of Stryker in the 4th quarter worth $123,000. Transce3nd LLC bought a new position in shares of Stryker in the 4th quarter worth $102,000. Finally, Seaview Investment Managers LLC lifted its holdings in shares of Stryker by 0.7% in the 4th quarter. Seaview Investment Managers LLC now owns 26,507 shares of the medical technology company's stock worth $9,544,000 after purchasing an additional 173 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Allan C. Golston sold 2,458 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the transaction, the director now directly owns 14,895 shares in the company, valued at $5,705,827.65. The trade was a 14.16 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Stryker Price Performance

Shares of NYSE:SYK traded up $4.29 during mid-day trading on Friday, reaching $365.34. The stock had a trading volume of 1,462,555 shares, compared to its average volume of 1,357,041. The company has a market cap of $139.45 billion, a P/E ratio of 47.08, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The business's 50 day moving average price is $367.81 and its 200 day moving average price is $373.43. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the business posted $3.46 EPS. Research analysts expect that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Wall Street Analysts Forecast Growth

SYK has been the topic of a number of recent research reports. Wells Fargo & Company increased their target price on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a report on Wednesday, January 29th. Citigroup reissued a "buy" rating and issued a $450.00 price target on shares of Stryker in a research report on Wednesday, February 26th. JMP Securities reissued a "market perform" rating on shares of Stryker in a research report on Tuesday, February 18th. Canaccord Genuity Group lifted their target price on Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. Finally, Barclays boosted their price target on shares of Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $423.53.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.